FAQ

Familial Partial Lipodystrophy, Type 3

Known as: FPLD3, Lipodystrophy, Familial Partial, Associated With PPARg Mutations, Lipodystrophy, Familial Partial, Type 3 
This type can be caused by mutation in the gene encoding PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2016
01220042016

Related topics

Related topics

14 relations
Acanthosis NigricansAutosomal dominant inheritanceGestational DiabetesHyperglycemia
(More)

Broader (1)

Familial partial lipodystrophy

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Familial Partial Lipodystrophy, Type 3
Hypertensive disease
Hyperglycemia
Autosomal dominant inheritance
Liver Cirrhosis
Pre-Eclampsia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Clinical Utility Gene Card for: Familial partial lipodystrophy
1. DISEASE CHARACTERISTICS 1.1 Name of the disease (synonyms) There are several subclasses of familial partial lipodystrophy… (More)
Is this relevant?
2016
2016
Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3.
OBJECTIVE Familial partial lipodystrophy type 3 (FPLD3) is an autosomal dominant disorder with loss of subcutaneous adipose… (More)
Is this relevant?
2012
2012
Vascular placental abnormalities and newborn death in a pregnant diabetic woman with familial partial lipodystrophy type 3: a possible role for peroxisome proliferator-activated receptor γ.
The peroxisome proliferator-activated receptor protein gamma (PPARγ), a nuclear receptor involved in adipocyte differentiation… (More)
Is this relevant?
2007
2007
Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.
The nuclear receptor peroxisome proliferator-activated receptor (PPAR) gamma plays a key role in the regulation of glucose and… (More)
Is this relevant?
2007
2007
Quantitative and qualitative differences in subcutaneous adipose tissue stores across lipodystrophy types shown by magnetic resonance imaging
BACKGROUND Lipodystrophies are characterized by redistributed subcutaneous fat stores. We previously quantified subcutaneous fat… (More)
  • table 1
  • table 2
Is this relevant?
2007
2007
Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.
CONTEXT Familial partial lipodystrophy (FPLD) results from coding sequence mutations either in LMNA, encoding nuclear lamin A/C… (More)
Is this relevant?
2006
2006
A frameshift mutation in peroxisome-proliferator-activated receptor-gamma in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367).
 
Is this relevant?
2005
2005
Peroxisomal proliferator activated receptor-γ deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)
Familial partial lipodystrophy (Dunnigan) type 3 (FPLD3, Mendelian Inheritance in Man [MIM] 604367) results from heterozygous… (More)
Is this relevant?
2005
2005
Lessons from human mutations in PPARgamma.
Familial partial lipodystrophy (FPLD) is characterized by adipose tissue repartitioning with multiple metabolic disturbances… (More)
Is this relevant?
2004
2004
A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy.
Familial partial lipodystrophy (FPLD) results from coding sequence mutations either in LMNA, encoding nuclear lamin A/C, or in… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?